Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CytomX Therapeutics Inc.

    NASDAQ: CTMX · Real-Time Price · USD
    1.90
    0.14 (7.95%)
    At close: Aug 15, 2025, 2:35 PM

    CytomX Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 138.1M 101.21M 53.16M 69.57M
    Cost of Revenue
    		 n/a n/a 5.86M 5.84M
    Gross Profit
    		 138.1M 101.21M 47.31M 63.73M
    Operating Income
    		 25M -6.48M -101.33M -83.78M
    Interest Income
    		 7.14M 9.84M 1.68M 255K
    Pretax Income
    		 32.09M 3.32M -99.32M -83.61M
    Net Income
    		 31.87M -569K -97.3M -80.65M
    Selling & General & Admin
    		 29.73M 30.02M 42.85M 39.16M
    Research & Development
    		 83.38M 77.68M 111.65M 114.19M
    Other Expenses
    		 n/a n/a 340K -83K
    Operating Expenses
    		 113.11M 107.7M 154.5M 153.35M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 113.11M 107.7M 154.5M 153.35M
    Income Tax Expense
    		 224K 3.89M -2.02M -2.96M
    Shares Outstanding (Basic)
    		 84.44M 73.81M 65.74M 64.15M
    Shares Outstanding (Diluted)
    		 84.75M 73.81M 65.74M 64.15M
    EPS (Basic)
    		 0.38 -0.01 -1.48 -1.26
    EPS (Diluted)
    		 0.38 -0.01 -1.48 -1.26
    EBITDA
    		 26.76M -4.31M -98.89M -113.34M
    EBIT
    		 25M -6.48M -101.33M -116.04M
    Depreciation & Amortization
    		 1.77M 2.17M 5.86M 5.84M

    Add to Watchlist